Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Not a single study

Story checked

CSHL researchers find way to make immunotherapy effective against colorectal cancer (opens in a new tab)

news-medical.net · 2026-10-14

Short answerEvidenceSource

Short answer

Not a single study

No clear answer.

The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

This story isn't reporting one study.

The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.

Open claim evidence
3

Search result

No single source study.

The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.

Source paper

Source layer

The paper behind the story

The source record for this check.

The research anchor for the report.

  • Also referencedpresented as the new finding

    Compartment-specific PPARδ activity controls the outcome of cancer–immune cell competition and immunotherapy efficacy

    Publisher (opens in a new tab)
Related research

Research nearby

Research on this topic

Nearby papers when the source is unclear.

and 34 more considered

Then inspect each claim

Evidence layer

Claim by claim

What the story asserts. With no source study, there is nothing to check these against.

Claim 1 of 5Not checkedCSHL researchers published new research in Nature Immunology suggesting that a transcription factor that usually promotes cancer growth can be turned into a cancer-fighting force inside the immune system.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 2 of 5Not checkedThe story says activating PPARD on the immune side turns a pro-cancer tumor environment into an anti-cancer arena in a mouse model of colorectal cancer.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 3 of 5Not checkedThe lab activated PPARD in CAR T cells and tested them on patient-derived organoids, human cancer cells in a dish, and human cancer cells implanted in mice; in each case, the PPARD-activated CAR T cells slowed or stopped tumor growth.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 4 of 5Not checkedThe article says the findings were also validated in other tumor types, including breast cancer, ovarian cancer, and melanoma.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 5 of 5Not checkedThe researchers are now applying the approach to endometriosis, which the article says lacks effective treatment.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Finally, the search trail

Method layer

No single source study was found.

NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.

Nearby research

No exact source, but these papers are close.

Crossref, PubMed, Europe PMC · 38 candidate papers

And 33 more candidates considered.